Skip to content

Selling a Pharmacy

Preparing a Pharmacy for Sale: Accounts, Margin Story and Tax

11 November 2026 · 9 min read

Get in touch

It's natural to start with what your business is worth. The more productive preparation question is what a buyer can verify and what HMRC will charge on the gain. Getting both right is the work of the two to three years before you exchange, not the two to three weeks.

There are two levers: a clean, defensible margin story that supports the price a buyer will pay, and Business Asset Disposal Relief (BADR) eligibility and timing that determines the tax you keep. Both require planning well in advance.

The two levers: price and tax

A pharmacy buyer's offer reflects two things: the income they can verify in your accounts, and the risk they price in for what they cannot. A seller's tax bill on the resulting gain reflects the BADR rate that applied on the day of disposal and whether the qualifying conditions were met at that point.

The two levers are independent. You can have immaculate accounts and poor BADR preparation, or the reverse. Both are controllable, both require time, and both directly determine how much you put in your pocket.

For an overview of the sale process and what to expect as a seller, see the selling a pharmacy hub.

Clean, reconciled accounts a buyer's due diligence will trust

A pharmacy's accounts look unusual to anyone trained on ordinary trade businesses. Income is not till-driven: it is reimbursement (Drug Tariff prices) plus remuneration (fees and service payments) under the Community Pharmacy Contractual Framework, flowing through a monthly FP34 NHSBSA payment cycle: an advance of the whole estimated claim around the 10th of the next month, then a settling-up payment two months after submission. A buyer's accountant knows this. What they are checking is whether your records reflect it accurately and consistently.

The specific lines they will interrogate are:

  • FP34 payment history. Three years of NHSBSA payment schedules reconciled to your bank statements. Missing months, unexplained credits, or advance-on-account balances that do not tie to the payment log are the first red flag.
  • Drug Tariff margin variances. Under the Drug Tariff and Category M clawback mechanism, gross margin is set centrally and moves as DHSC resets Category M prices each quarter. If your accounts show margin swings with no corresponding note or management explanation, a buyer will discount the revenue quality. The fix is a margin-variance note in your management accounts, not a restatement.
  • VAT treatment. A community pharmacy is a VAT-mixed business: NHS-dispensed prescription drugs are zero-rated, over-the-counter medicines are standard-rated. Your retail scheme (the mechanic for splitting takings) must be disclosed and consistent across the three years. A buyer's accountant will check that the scheme chosen is appropriate and that the zero-rated/standard-rated split is defensible. Inconsistent treatment is an audit risk that transfers to the buyer on a share purchase.
  • Retail and service income separated. OTC retail sales and growing service lines such as Pharmacy First should be separately coded, not lumped into a single income line. Buyers pay for visibility, not aggregation.

Three years of clean, consistently coded management accounts with a margin-variance note and an FP34 reconciliation schedule is the minimum a credible buyer process requires. Start the cleanup now if those records are not already in that shape.

The margin story: evidencing Drug Tariff and Category M margin

Pharmacy valuation depends heavily on the quality and defensibility of the income, not just its size. Because Drug Tariff and Category M pricing is set centrally and Category M prices are reset each quarter, gross margin in a pharmacy varies in ways that are outside the owner's control. A buyer who does not understand this will either price the risk in (lower offer) or walk away.

The margin story is the narrative that explains variance: which months were affected by Drug Tariff adjustments, how the business responded, what the underlying dispensing volume trend is, and how the retail and service income lines diversify the revenue base. It is not a restatement of the accounts; it is the management commentary that makes the accounts intelligible to a buyer who is spending serious money.

A well-prepared margin story includes:

  • A three-year margin-by-revenue-line table (NHS reimbursement, NHS remuneration, OTC retail, services) showing the split and the trend.
  • Annotations for significant Drug Tariff adjustment months so a buyer can separate structural performance from external price movements.
  • Dispensing volume data (items per month) as a proxy for the NHS contract strength, which is the core asset being acquired.
  • A brief note on Pharmacy First and other service income growth, showing the trajectory as a separate line.

Buyers pay a premium for earnings quality they can verify and a discount for earnings they cannot explain. The margin story is the document that shifts the negotiation in your direction.

For a detailed look at how goodwill and valuation methods work in pharmacy transactions, see the pharmacy goodwill valuation post.

Business Asset Disposal Relief: what qualifies and how to prepare

Business Asset Disposal Relief (BADR) reduces the capital gains tax rate on qualifying disposals to 18% for 2026/27, on gains up to a £1m lifetime limit per person. From 6 April 2027 the lifetime limit is due to fall from £1 million to £500,000 (announced at Budget 2026 on 28 October 2026, still to pass in the Finance Bill). It can save an exiting owner a lot of tax, but it requires that the qualifying conditions are met at the date of disposal, not just around it.

The core qualifying conditions for a disposal of shares in a personal company are:

  • You must have held the shares for at least two years before the date of disposal.
  • Throughout that two-year period, the company must have been a trading company (or the holding company of a trading group).
  • You must have held at least 5% of the ordinary share capital and at least 5% of the voting rights throughout the two years, and been entitled to at least 5% of either the distributable profits and assets on a winding up or the sale proceeds.
  • You must have been an officer or employee of the company throughout the two years.

For a sole-trader or partnership disposal, the business must have been owned and operated as a qualifying trade for at least two years before disposal.

Two preparation points matter most in practice. First, any restructuring (incorporating a sole-trader business, changing the share structure, admitting a new director, or converting to a holding company) resets or complicates the two-year clock. Run any planned restructuring past a specialist before signing anything, not after. Second, the £1m lifetime limit is per person. If you have used part of the allowance on a previous qualifying disposal, only the remainder is available. Check your position now so there are no surprises at the point of a sale.

For a full tax computation, visit the pharmacy sale CGT and BADR service page or speak to us directly about your specific situation.

Timing around the BADR rate steps

The BADR rate has changed twice in recent years and may change again. The history matters because a disposal date determines which rate applies:

Tax year BADR rate on qualifying gains (up to £1m lifetime limit)
Before 2025/26 10%
2025/26 (6 April 2025 to 5 April 2026) 14%
2026/27 (6 April 2026 onwards) 18%

Source: gov.uk/business-asset-disposal-relief.

To make the rate-step arithmetic concrete, the table below illustrates the difference on a qualifying gain of £500,000 (fully within the £1m BADR lifetime limit, figures illustrative and for planning purposes only):

Disposal year BADR rate CGT on £500,000 qualifying gain (illustrative)
2025/26 14% £70,000
2026/27 18% £90,000
Difference 4 percentage points £20,000 more tax in 2026/27 on the same gain

These figures are illustrative. They do not account for the annual exempt amount, any gains within the basic-rate band, deferred consideration or earn-out timing, or any individual circumstances that would change the calculation. The point is structural: four percentage points on a £500,000 gain is £20,000. On a gain closer to the £1m limit the number doubles. Disposal timing is a real financial decision, not a formality.

The rate for 2026/27 is 18%. A future Budget can change it; there is no published commitment to hold it there. Budget 2026 (28 October 2026) left the rate alone but did announce a cut to the lifetime limit, from £1 million to £500,000 for disposals from 6 April 2027 (still to pass in the Finance Bill). Special rules apply where contracts are exchanged before 6 April 2027 but complete on or after it: the £500,000 limit can still apply unless the parties to the contract can show it was not entered into to gain a tax advantage from the timing (and, where they are connected, that it was for wholly commercial reasons), so exchanging early is not a safe way to keep the £1m limit. If your BADR remaining lifetime allowance is substantial and your exit is within reach, the timing calculation is worth running properly before you commit to a target completion date.

To discuss the numbers for your situation, speak to us or visit the pharmacy sale CGT and BADR service page.

Put in the sale price, your base cost and the completion date to see the capital gains tax under today's BADR lifetime limit and under the lower limit announced from 6 April 2027.

Calculator

Pharmacy sale tax estimator: what you pay before and after the April 2027 BADR change

Put in the price, what the pharmacy or your shares cost you, your selling costs and any BADR you've already used. We'll show the CGT with BADR's £1 million lifetime limit, the CGT with the £500,000 limit announced for disposals from 6 April 2027 (still to pass in the Finance Bill), the difference, and when the tax's due. It's for a sole trader or partner selling the business, or a shareholder selling their shares. Every figure already in the boxes is an example, so replace it with your own.

If the company sells the business, the company pays corporation tax on its gain, not CGT, and BADR doesn't apply to it. This tool doesn't cover that route.

£

What you're getting for the business or your shares, including any fixed sum paid after completion. If you own the pharmacy with someone else, enter your own share: each owner has their own BADR limit and annual exempt amount. For an earn-out that depends on future results, include only what the right to it is worth at the sale.

£

For a business you bought, what you paid for the goodwill and the other assets you're now selling, plus the costs of buying them. For shares, what you paid for them. If you opened the pharmacy yourself, there may be little or nothing here.

£

Money spent adding to the value of what you're selling (not repairs or running costs), plus the costs of the sale itself, such as broker, legal and valuation fees.

For CGT a sale happens when the contract's made, or when its last condition's met, not at completion (TCGA 1992 s28). That's why the next box matters if you complete on or after 6 April 2027.

£

The total of gains you've claimed BADR (or Entrepreneurs' Relief, its old name) on in earlier sales. They count against the £1 million now and, as announced, against the £500,000 too.

£

Salary, business profits, pension, rent, dividends and interest. We take off the standard £12,570 Personal Allowance to find how much of the £37,700 basic-rate band is left. Your BADR gain uses the band first, so it only changes the figures for gain outside BADR.

£

Gains on anything else you sell in the same tax year, less any losses. They're taxed at 18% or 24% too, and they share your annual exempt amount.

Your result

Your answer's ready. Press below to see it.

Beyond BADR: standard CGT if the gain exceeds the limit

Where your gain exceeds the £1m BADR lifetime limit, the excess is taxed at 24%, because the BADR gain uses up the basic-rate band first. Where BADR does not apply for any reason, the gain is subject to standard CGT rates:

  • 18% on gains that fall within the remaining basic-rate band (after income for the year has been taken into account).
  • 24% on gains above the basic-rate band.

The annual exempt amount is frozen at £3,000 for 2026/27. It is deducted from the total gain before the rate is applied, but against a six-figure gain it makes a small difference to the total bill.

The 18%/24% split applies to the gain whether the pharmacy premises are owned or leased: gov.uk's current rates don't set a separate rate for residential property.

Two structuring points are worth understanding early. First, deferred money is taxed in one of two ways. A fixed deferred amount counts in full at the date of disposal, before you receive it (HMRC manual CG14881), though instalments over more than 18 months let you ask to pay the tax in instalments too. A contingent earn-out is valued as a right at the disposal, and each later payment is a disposal of that right, taxed in the year you get it and without the BADR given on the sale (CG14970). Second, if the sale is structured as a share sale, the CGT is on the gain on your shares, not on the underlying business assets separately. If it's an asset sale by your company, the company pays corporation tax on its gains and you're taxed again when you take the money out; a sole trader or partner selling assets pays CGT on each of them. The choice of deal structure changes both the tax liability and the BADR eligibility calculation.

These are areas where a specialist computation matters. For modelling your specific numbers, contact us or see the pharmacy sale CGT and BADR service.

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

Building the timeline: what to fix now versus at deal time

The work that moves a pharmacy sale outcome happens before a buyer is at the table, not after. Here's when to tackle each of the main preparation tasks.

Area What a buyer or adviser checks Fix now (2+ years out) Deal-time (3 to 6 months from exchange)
FP34 payment history NHSBSA payment schedule reconciled to bank Request and file monthly; reconcile any gaps Assemble three-year schedule for data room
Drug Tariff margin variances Explained variance by month Add management-account annotations now Prepare margin-story narrative document
VAT retail scheme Scheme is appropriate and consistently applied Review choice and document the basis Confirm three-year consistency in disclosure
Revenue separation NHS reimbursement / remuneration / OTC / services coded separately Recode the chart of accounts if mixed Produce revenue-by-line three-year summary
BADR qualifying period Two-year ownership, officer/employment, 5% shares and votes Verify position now; flag restructuring risks Confirm qualifying conditions are still met at exchange date
BADR lifetime limit Prior qualifying disposals and limit remaining Check prior use of the allowance Confirm remaining limit before heads of terms
Deal structure Share vs asset purchase; earn-out mechanics Understand the default structure for your situation Agree structure before heads of terms are signed
GPhC and NHS regulatory steps GPhC premises entry and superintendent pharmacist (Medicines Act 1968 ss71, 74A, 74B); the buyer's change of ownership application under the 2013 Regulations Understand the steps and who handles each Trigger regulatory process in parallel with legal

The regulatory timeline under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 and for the premises entry in the GPhC register runs in parallel with the legal process, not after it. Build it into your overall plan from the start.

Next steps

Preparing a pharmacy for sale is a two to three year project if the accounts need work or the BADR qualifying conditions are not yet in place. The earlier you start, the more of the preparation is controlled rather than rushed.

The selling a pharmacy hub sets out how specialist accountants support the sale process from preparation through to completion and post-deal tax filing. For a conversation about your specific situation, including a BADR eligibility check and a sense of the tax landscape on your expected gain, get in touch.

Frequently asked questions

Produce three years of reconciled accounts that separate NHS reimbursement income, Drug Tariff margin variances, retail OTC sales, and service income such as Pharmacy First. Ensure your FP34 NHSBSA payment history is complete and your VAT retail-scheme treatment is consistent. A buyer's accountant will test each line independently, so unexplained variances kill confidence and price.

Business Asset Disposal Relief (BADR) charges capital gains tax at 18% for 2026/27 on qualifying disposals up to a £1m lifetime limit per person (due to fall to £500,000 for disposals from 6 April 2027, announced at Budget 2026 on 28 October 2026 and not yet law). To qualify, the conditions must hold for at least two years up to the date of disposal. Selling the business as a sole trader or partner, you must have owned it for that long. Selling shares, the company must be a trading company (or the holding company of a trading group), you must be an employee or office holder, and you must hold at least 5% of the shares and voting rights and be entitled to at least 5% of either the distributable profits and assets on a winding up or the sale proceeds. HMRC's guidance is at gov.uk/business-asset-disposal-relief.

Gains covered by BADR are taxed at 18% (2026/27) up to the £1m lifetime limit (due to fall to £500,000 for disposals from 6 April 2027, announced at Budget 2026 on 28 October 2026 and not yet law). Gains above the limit are taxed at 24%, because the BADR gain uses up the basic-rate band first. Where BADR does not apply, gains are taxed at 18% within any remaining basic-rate band and 24% above it. The annual exempt amount is £3,000.

The BADR lifetime limit is £1m per person today. From 6 April 2027 the lifetime limit is due to fall from £1 million to £500,000 (announced at Budget 2026 on 28 October 2026, still to pass in the Finance Bill). It is not per company and not per disposal. If you have used any of the limit on a previous qualifying disposal, only the remainder is available.

Yes. BADR rose from 14% to 18% on 6 April 2026. A disposal made in 2025/26 faced 14% on qualifying gains; the same gain in 2026/27 faces 18%. The rate may change again in future Budgets, so understanding where you stand against the £1m lifetime limit (due to fall to £500,000 from 6 April 2027) and the current rate is part of every exit plan.

Buyers and their advisers want three years of accounts with clear separation of NHS reimbursement (Drug Tariff prices), remuneration (fees and service income), and retail OTC sales. They will cross-reference the FP34 NHSBSA payment schedule, check the VAT retail-scheme treatment, and test whether Drug Tariff margin variances are explained. Unexplained swings, mixed VAT treatment, or missing payment history records are the due-diligence red flags they look for.

Related reading

Need help with your pharmacy finances?

Tell us about your situation and we will come back within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)